Pancreatic Cancer Research

ResearcherHunan Normal UniversityActive in the last 2 years

Ning Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7416-1494; OpenAlex author ID A5101973906. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. JS-K Combined with a Melanin-Based Theranostic Agent: A Novel Sequential Delivery Strategy to Enhance the Near-Infrared Fluorescence Imaging of Pancreatic Duct… Co-author DOI 10.1021/acs.analchem.3c04914↗
  2. Endoscopically guided interventional photodynamic therapy for orthotopic pancreatic ductal adenocarcinoma based on NIR-II fluorescent nanoparticles. Co-author DOI 10.7150/thno.84164↗
  3. Identification of Circ_001569 as a Potential Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer. Last author DOI 10.1177/1533033820983302↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hong‐Wen Liu · 2 shared papers, 2023–2024 · strength 0.36
  2. Wei Cheng · 2 shared papers, 2023–2024 · strength 0.36
  3. Manxiong Dai · 1 shared paper, 2024 · strength 0.21
  4. Kang Chen · 1 shared paper, 2024 · strength 0.21
  5. Lei Zhou · 1 shared paper, 2024 · strength 0.21
  6. Xianbo Shen · 1 shared paper, 2021 · strength 0.16
  7. Xu Chen · 1 shared paper, 2023 · strength 0.15
  8. Sulai Liu · 1 shared paper, 2023 · strength 0.15
  9. Yan Liao · 1 shared paper, 2023 · strength 0.15
  10. Kang Chen · 1 shared paper, 2023 · strength 0.15
  11. Guosheng Song · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.